What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Estudio de intervención, abierto y exploratorio para investigar la seguridad, la tolerabilidad, la farmacocinética y la eficacia de Lu AF28996 en pacientes con enfermedad de Parkinson Contact Protocol code: 18252A EudraCT code: No aplica Pathology: Malalties del sistema nerviós Principal investigator: Hernández Vara, Jorge Research group: Malalties neurodegeneratives Service: Neurologia Phase: Fase II Recruiting: Open Status: Iniciat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase III, doble ciego y comparativo con placebo para evaluar la eficacia y la seguridad del plozasirán en adultos con hipertrigliceridemia Contact Protocol code: AROAPOC3-3009 EudraCT code: No aplica Pathology: Malalties endocrines, nutricionals i metabòliques Principal investigator: Ortiz Zúñiga, Angel Michael Research group: Diabetis i metabolisme Service: Endocrinologia Phase: Fase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio en fase 3, aleatorizado, doble ciego, controlado con placebo, y de grupos paralelos para evaluar la eficacia y la seguridad de dupilumab en el tratamiento del prurito del liquen simple crónico (LSC) en adultos Contact Protocol code: EFC18365 EudraCT code: No aplica Pathology: Malalties de la pell i del teixit subcutani Principal investigator: Mollet Sánchez, Jordi Research group: Recerca Biomèdica en Melanoma Service: Dermatologia Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio en fase I/Ib, abierto, de ORIC-944 en monoterapia o en combinacion con uninhibidor de la via del receptor androgenico en pacientes con cancer de prostata metastasico Contact Protocol code: ORIC-944-01 EudraCT code: No aplica Pathology: Tumors Principal investigator: Valderrama Rodríguez, Angelica Service: Sense classificar Phase: Fase I Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Active, Non-Infectious Intermediate-, Posterior-, and Panuveitis Contact Protocol code: PVT-2201-303 EudraCT code: No aplica Pathology: Malalties de l’ull i dels seus annexos Principal investigator: Kirkegaard Biosca, Eric Research group: Oftalmologia Service: Oftalmologia Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A Phase III, Randomised, Double-blind, Placebo-controlled,Multicentre, Parallel-group Study with Extension Phase to Evaluate the Efficacy andSafety of Dysport® for the Prevention of Episodic Migraine in Adult Participants. Contact Protocol code: CLIN-52120-464 EudraCT code: No aplica Pathology: Nervous system diseases Principal investigator: Pozo Rosich, Patricia Research group: Cefalea i dolor neurològic Service: Neurology Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio aleatorizado, doble ciego, controlado con placebo, de fase 3 y con diseño de grupos paralelosen el que se evalúa la eficacia y seguridad de efgartigimod PH20 por vía s.c. administrado mediante jeringaprecargada en participantes adultos con miastenia grave ocular Contact Protocol code: ARGX-113-2315 EudraCT code: No aplica Pathology: Nervous system diseases Principal investigator: Juntas Morales, Raul Research group: Sistema nerviós perifèric Service: Neurology Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Disorder with Insomnia Symptoms Contact Protocol code: 42847922MDD3003 EudraCT code: No aplica Pathology: Trastorns mentals i del comportament Principal investigator: Rodriguez Lopez, Amanda Service: Unclassified Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase III, doble ciego y comparativo con placebo para evaluar la eficacia y laseguridad del plozasirán en adultos con hipertrigliceridemia grave (estudio SHASTA 3)'Promotor: Arrowhead Pharmaceuticals Inc. Contact Protocol code: AROAPOC3-3003 EudraCT code: No aplica Pathology: Tumors Principal investigator: Ortiz Zuñiga, Angel Michael Research group: Diabetes and Metabolism Service: Endocrinology Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase 2, aleatorizado, comparativo con placebo, dobleciego y de grupos paralelos para evaluar la eficacia y la seguridad de MK-1167 comotratamiento complementario en participantes con demencia de tipo Alzheimer leve omoderada Contact Protocol code: MK-1167-008 EudraCT code: No aplica Pathology: Nervous system diseases Principal investigator: Delgado Martínez, Maria Pilar Research group: Malalties neurovasculars Service: Neurology Phase: Phase II Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase 3, multicéntrico, aleatorizado, doble enmascarado,controlado con tratamiento simulado y con 2 grupos paralelos sobre la eficacia, laseguridad y la tolerabilidad de ANX007 administrado mediante inyección intravítrea enpacientes con atrofia geográfica (AG) secundaria a degeneración macular asociada ala edad (DMAE). Contact Protocol code: ANX007-GA-02 EudraCT code: No aplica Pathology: Diseases of the eye and its adnexa Principal investigator: Zapata Victori, Miguel Angel Research group: Ophtalmology Service: Ophthalmology Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A phase 3, multicenter, double blind, placebo-controlled, randomized withdrawal trial to evaluate the efficacy, safety, and pharmacokinetics of deucravacitinib in children and adolescents from 5 to less than 18 years of age with active juvenile psoriatic arthritis Contact Protocol code: IM011-1071 EudraCT code: No aplica Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més Principal investigator: Lopez Corbeto, Mireia Research group: Reumatologia Service: Reumatologia Phase: Phase III Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Year 2025 Referencia Rev Neurol. 2025 Feb 12;80(1):37744. doi: 10.31083/RN37744. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.31083/RN37744 Revista REVISTA DE NEUROLOGIA Títol Complet A Rare Guillain-Barre Syndrome Variant with Multi-Ganglioside Reactivity: A Case of Severe Cranial Nerve Involvement. Autors Nuria Raguer Sanz Marc Rodrigo Gisbert Codi 75257 PMID https://pubmed.ncbi.nlm.nih.gov/40084652 Nom Autors Girame-Rizzo, Lidia; Gomez-Dabo, Laura; Gonzalez, Victoria; Iza-Achutegui, Maider; Juntas, Raul; Lazaro-Hernandez, Carlos; Llaurado, Arnau; Lopez-Maza, Samuel; Montalvo-Olmedo, Carmen; Raguer, Nuria et al. DOI número 10.31083/RN37744 Year 2025 Referencia Front Psychiatry. 2025 Feb 27;16:1446970. doi: 10.3389/fpsyt.2025.1446970. eCollection 2025. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.3389/fpsyt.2025.1446970 Revista Frontiers in Psychiatry Títol Complet Gender differences in ADHD and impulsivity among alcohol or alcohol- and cocaine-dependent patients. Codi 75258 PMID https://pubmed.ncbi.nlm.nih.gov/40084061 Nom Autors Aguilar, Lourdes; Alvarez-Navares, Ana; Buch-Vicente, Barbara; Garcia-Ullan, LLanyra; Gonzalez-Bolanos, Kristofer Ramon; Grau-Lopez, Lara; Palma-Alvarez, Raul Felipe; Perez, Jesus; Remon-Gallo, Diego; Roncero, Carlos et al. DOI número 10.3389/fpsyt.2025.1446970 Year 2025 Referencia J Pediatr Urol. 2025 Feb 27:S1477-5131(25)00122-6. doi: 10.1016/j.jpurol.2025.02.031. Tipus publicació Other (letters to the editor, abstracts, corrigendum, etc.) DOI http://dx.doi.org/10.1016/j.jpurol.2025.02.031 Revista Journal of Pediatric Urology Títol Complet Response to comment: Modified J-shaped incision for combined pediatric liver-kidney transplants (CLKT): Focusing on the urological outcomes. Autors Marino Asensio Llorente Romy Gander Codi 75260 PMID https://pubmed.ncbi.nlm.nih.gov/40082148 Nom Autors Asensio, Marino; Gander, Romy; Gonzalez-Barba, Isabel; Molino, Jose Andres et al. DOI número 10.1016/j.jpurol.2025.02.031 Year 2025 Referencia Enferm Infecc Microbiol Clin (Engl Ed). 2025 Mar 12:S2529-993X(25)00053-X. doi: 10.1016/j.eimce.2024.04.015. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.eimce.2024.04.015 Títol Complet Reduction of surgical site infection rates in elective colorectal surgery by means of a nationwide interventional surveillance programme. A cohort study. Autors Alejandro Solis Peña Codi 75261 PMID https://pubmed.ncbi.nlm.nih.gov/40082120 Nom Autors Abad-Torrent, Ana; Almendral, Alexander; Badia, Josep M; Flores-Yelamos, Miriam; Fraccalvieri, Domenico; Gomila-Grange, Aina; Hernandez, Merce; Limon, Enric; Lopez, Lucrecia; Pares, David et al. DOI número 10.1016/j.eimce.2024.04.015 Year 2025 Referencia Actas Dermosifiliogr. 2025 Mar 11:S0001-7310(25)00139-5. doi: 10.1016/j.ad.2025.03.008. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.ad.2025.03.008 Revista Actas Dermo-Sifiliograficas Títol Complet Estudio prospectivo multicentrico de casos y controles del exposoma en melanoma. Autors Carlos González Cruz Codi 75268 PMID https://pubmed.ncbi.nlm.nih.gov/40081473 Nom Autors Abadias-Granado, I; Almagro, M; Almenara-Blasco, M; Arias-Santiago, S; Banuls, J; Buendia-Eisman, A; Colmenero, M; De-la-Fuente-Meira, S; Diago, A; Florez, A et al. DOI número 10.1016/j.ad.2025.03.008 Year 2025 Referencia Pediatr Nephrol. 2025 Mar 13. doi: 10.1007/s00467-025-06717-1. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1007/s00467-025-06717-1 Revista PEDIATRIC NEPHROLOGY Títol Complet Predictors of hyperkalemia in pediatric patients on dialysis: international prospective observational study. Autors Alejandro Cruz Gual Codi 75271 PMID https://pubmed.ncbi.nlm.nih.gov/40080184 Nom Autors Bakkaloglu, Sevcan A; Consolo, Silvia; Edefonti, Alberto; Grassi, Francesca Sofia; Grassi, Maria R; Gual, Alejandro Cruz; Jankauskiene, Augustina; McAlister, Louise; Paglialonga, Fabio; Puccio, Giuseppe et al. DOI número 10.1007/s00467-025-06717-1 Year 2025 Referencia Eur Geriatr Med. 2025 Mar 15. doi: 10.1007/s41999-025-01173-4. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1007/s41999-025-01173-4 Revista European Geriatric Medicine Títol Complet The perceptions of European geriatricians on the co-occurrence and links between dementia, delirium and frailty. Autors Alessandro Morandi Codi 75276 PMID https://pubmed.ncbi.nlm.nih.gov/40088358 Nom Autors Bellelli, Giuseppe; Bo, Mario; Brunetti, Enrico; Cherubini, Antonio; Coin, Alessandra; Curtin, Catriona; Faherty, Mary; Fedecostante, Massimiliano; Ferrara, Maria Cristina; Morandi, Alessandro et al. DOI número 10.1007/s41999-025-01173-4 Year 2025 Referencia United European Gastroenterol J. 2025 Mar 15. doi: 10.1002/ueg2.70011. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1002/ueg2.70011 Revista United European Gastroenterology Journal Títol Complet European Consensus on Malabsorption-UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN: Part 2: Screening, Special Populations, Nutritional Goals, Supportive Care, Primary Care Perspective. Autors Oscar Segarra Canton Codi 75277 PMID https://pubmed.ncbi.nlm.nih.gov/40088199 Nom Autors Arvanitakis, Marianna; Broekaert, Ilse; Burgos, Rosa; Corazza, Gino Roberto; Derovs, Aleksejs; Di Sabatino, Antonio; Dolinsek, Jernej; Dumitrascu, Dan Lucian; Fonseca, Jorge; Foteini, Anastasiou et al. DOI número 10.1002/ueg2.70011 Pagination First page « Previous page ‹ … Page 319 Page 320 Current page 321 Page 322 Page 323 … Next page › Last page »
Year 2025 Referencia Rev Neurol. 2025 Feb 12;80(1):37744. doi: 10.31083/RN37744. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.31083/RN37744 Revista REVISTA DE NEUROLOGIA Títol Complet A Rare Guillain-Barre Syndrome Variant with Multi-Ganglioside Reactivity: A Case of Severe Cranial Nerve Involvement. Autors Nuria Raguer Sanz Marc Rodrigo Gisbert Codi 75257 PMID https://pubmed.ncbi.nlm.nih.gov/40084652 Nom Autors Girame-Rizzo, Lidia; Gomez-Dabo, Laura; Gonzalez, Victoria; Iza-Achutegui, Maider; Juntas, Raul; Lazaro-Hernandez, Carlos; Llaurado, Arnau; Lopez-Maza, Samuel; Montalvo-Olmedo, Carmen; Raguer, Nuria et al. DOI número 10.31083/RN37744
Year 2025 Referencia Front Psychiatry. 2025 Feb 27;16:1446970. doi: 10.3389/fpsyt.2025.1446970. eCollection 2025. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.3389/fpsyt.2025.1446970 Revista Frontiers in Psychiatry Títol Complet Gender differences in ADHD and impulsivity among alcohol or alcohol- and cocaine-dependent patients. Codi 75258 PMID https://pubmed.ncbi.nlm.nih.gov/40084061 Nom Autors Aguilar, Lourdes; Alvarez-Navares, Ana; Buch-Vicente, Barbara; Garcia-Ullan, LLanyra; Gonzalez-Bolanos, Kristofer Ramon; Grau-Lopez, Lara; Palma-Alvarez, Raul Felipe; Perez, Jesus; Remon-Gallo, Diego; Roncero, Carlos et al. DOI número 10.3389/fpsyt.2025.1446970
Year 2025 Referencia J Pediatr Urol. 2025 Feb 27:S1477-5131(25)00122-6. doi: 10.1016/j.jpurol.2025.02.031. Tipus publicació Other (letters to the editor, abstracts, corrigendum, etc.) DOI http://dx.doi.org/10.1016/j.jpurol.2025.02.031 Revista Journal of Pediatric Urology Títol Complet Response to comment: Modified J-shaped incision for combined pediatric liver-kidney transplants (CLKT): Focusing on the urological outcomes. Autors Marino Asensio Llorente Romy Gander Codi 75260 PMID https://pubmed.ncbi.nlm.nih.gov/40082148 Nom Autors Asensio, Marino; Gander, Romy; Gonzalez-Barba, Isabel; Molino, Jose Andres et al. DOI número 10.1016/j.jpurol.2025.02.031
Year 2025 Referencia Enferm Infecc Microbiol Clin (Engl Ed). 2025 Mar 12:S2529-993X(25)00053-X. doi: 10.1016/j.eimce.2024.04.015. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.eimce.2024.04.015 Títol Complet Reduction of surgical site infection rates in elective colorectal surgery by means of a nationwide interventional surveillance programme. A cohort study. Autors Alejandro Solis Peña Codi 75261 PMID https://pubmed.ncbi.nlm.nih.gov/40082120 Nom Autors Abad-Torrent, Ana; Almendral, Alexander; Badia, Josep M; Flores-Yelamos, Miriam; Fraccalvieri, Domenico; Gomila-Grange, Aina; Hernandez, Merce; Limon, Enric; Lopez, Lucrecia; Pares, David et al. DOI número 10.1016/j.eimce.2024.04.015
Year 2025 Referencia Actas Dermosifiliogr. 2025 Mar 11:S0001-7310(25)00139-5. doi: 10.1016/j.ad.2025.03.008. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.ad.2025.03.008 Revista Actas Dermo-Sifiliograficas Títol Complet Estudio prospectivo multicentrico de casos y controles del exposoma en melanoma. Autors Carlos González Cruz Codi 75268 PMID https://pubmed.ncbi.nlm.nih.gov/40081473 Nom Autors Abadias-Granado, I; Almagro, M; Almenara-Blasco, M; Arias-Santiago, S; Banuls, J; Buendia-Eisman, A; Colmenero, M; De-la-Fuente-Meira, S; Diago, A; Florez, A et al. DOI número 10.1016/j.ad.2025.03.008
Year 2025 Referencia Pediatr Nephrol. 2025 Mar 13. doi: 10.1007/s00467-025-06717-1. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1007/s00467-025-06717-1 Revista PEDIATRIC NEPHROLOGY Títol Complet Predictors of hyperkalemia in pediatric patients on dialysis: international prospective observational study. Autors Alejandro Cruz Gual Codi 75271 PMID https://pubmed.ncbi.nlm.nih.gov/40080184 Nom Autors Bakkaloglu, Sevcan A; Consolo, Silvia; Edefonti, Alberto; Grassi, Francesca Sofia; Grassi, Maria R; Gual, Alejandro Cruz; Jankauskiene, Augustina; McAlister, Louise; Paglialonga, Fabio; Puccio, Giuseppe et al. DOI número 10.1007/s00467-025-06717-1
Year 2025 Referencia Eur Geriatr Med. 2025 Mar 15. doi: 10.1007/s41999-025-01173-4. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1007/s41999-025-01173-4 Revista European Geriatric Medicine Títol Complet The perceptions of European geriatricians on the co-occurrence and links between dementia, delirium and frailty. Autors Alessandro Morandi Codi 75276 PMID https://pubmed.ncbi.nlm.nih.gov/40088358 Nom Autors Bellelli, Giuseppe; Bo, Mario; Brunetti, Enrico; Cherubini, Antonio; Coin, Alessandra; Curtin, Catriona; Faherty, Mary; Fedecostante, Massimiliano; Ferrara, Maria Cristina; Morandi, Alessandro et al. DOI número 10.1007/s41999-025-01173-4
Year 2025 Referencia United European Gastroenterol J. 2025 Mar 15. doi: 10.1002/ueg2.70011. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1002/ueg2.70011 Revista United European Gastroenterology Journal Títol Complet European Consensus on Malabsorption-UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN: Part 2: Screening, Special Populations, Nutritional Goals, Supportive Care, Primary Care Perspective. Autors Oscar Segarra Canton Codi 75277 PMID https://pubmed.ncbi.nlm.nih.gov/40088199 Nom Autors Arvanitakis, Marianna; Broekaert, Ilse; Burgos, Rosa; Corazza, Gino Roberto; Derovs, Aleksejs; Di Sabatino, Antonio; Dolinsek, Jernej; Dumitrascu, Dan Lucian; Fonseca, Jorge; Foteini, Anastasiou et al. DOI número 10.1002/ueg2.70011
